View Author
response patient aspergillu fumigatu infection study dectin receptor conidia effect treatment cytokine tlr 2 floxacin aspergillosi fumigatus conidia prophylaxi level abscess control production disease -17 outcome therapy signi aspergillus fumigatus moxi floxacin candida macrophage university recognition result factor trend galactomannan albicans fraction baseline pathogen y 238x polymorphism aspergillus conidia analysis trova floxacin il -17 group flammatory hyphae strain netherland erasmus university rotterdam tlr 4 fragili immunol rmg-csf antibiotic fi ndings polymorphism defense b-glucan survival toll-like system pathway trova il -6 concentration candida albicans nijmegen downloaded host defense cohort expression van der meer monocyte immunity model antifungal erasmu hospital
10 Most Recent Publications
|
Early Serum Galactomannan Trend as a Predictor of Outcome of
Invasive Aspergillosis
(Article)
Chai, L.Y.A. Kullberg, B.J. Herbrecht, R. Johnson, E.M. Teerenstra, S. Khin, L.W. Maertens, J. Lortholary, O. Donnelly, P.J. Schlamm, H.T. Troke, P.F. |
2012-07-01
|
|
The Y238X stop codon polymorphism in the human b-glucan receptor dectin-1 and susceptibility to invasive aspergillosis
(Article)
Chai, L.Y.A. Boer, M.G.J. de Donnelly, P.J. Kullberg, B.J. Maertens, J. Netea, M.G. Velden, W.J.F.M. van der Plantinga, T.S. Spriel, A.B. van Jacobs, C. Halkes, C.J.M. Vonk, A.G. Blijlevens, N.M. Dissel, J.T. van |
2011-03-01
|
|
Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses
(Article)
Chai, L.Y.A. Vonk, A.G. Kullberg, B.J. Verweij, P.E. Verschueren, I. Meer, J.W.M. van der Joosten, L.A.B. Latgé, J.P. Netea, M.G. |
2011-02-01
|
|
Immune response to Aspergillus fumigatus in compromised hosts: From bedside to bench
(Article)
Chai, L.Y.A. Vonk, A.G. Kullberg, B.J. Netea, M.G. |
2011-01-01
|
|
Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive aspergillosis
(Article)
Chai, L.Y.A. Netea, M.G. Teerenstra, S. Earnest, A. Vonk, A.G. Schlamm, H.T. Herbrecht, R. Troke, P.F. Kullberg, B.J. |
2010-11-01
|
|
Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
(Article)
Chai, L.Y.A. Veerdonk, F. van de Kullberg, B.J. Netea, M.G. Marijnissen, R.J. Cheng, S.C. Khoo, A.L. Hectors, M. Lagrou, K. Vonk, A.G. Maertens, J. Joosten, L.A.B. |
2010-05-01
|
|
Fungal strategies for overcoming host innate immune response
(Article)
Chai, L.Y.A. Netea, M.G. Vonk, A.G. Kullberg, B.J. |
2009-08-17
|
|
Modulation of toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus
(Article)
Chai, L.Y.A. Kullberg, B.J. Vonk, A.G. Warris, A. Cambi, A. Latgé, J.P. Joosten, L.A.B. Meer, J.W.M. van der Netea, M.G. |
2009-05-01
|
|
Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: Timely administration is the most important factor
(Article)
Kasteren, M.E.E. van Manniën, J. Ott, A. Kullberg, B.J. Boer, A.S. de Gyssens, I.C.J. |
2007-04-01
|
|
Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.
(Article)
Stearne, L.E.T. Vonk, A.G. Kullberg, B.J. Gyssens, I.C.J. |
2005-09-01
|
